Did you mean leaf?
Displaying drugs 551 - 552 of 552 in total
Amrubicin
Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January...
Investigational
Methoxyamine
Investigational
Displaying drugs 551 - 552 of 552 in total